Who Paid My Doc Search
Menu
Organisation paid for research Program year 2024 Source: CMS Open Payments

Wr-McCr, LLC

Neither a doctor nor a teaching hospital

Research payments

$14,338,476

577 payments

Through program year 2024, Wr-McCr, LLC is reported as receiving $14,338,476 in research payments, across 577 payments.

By program year

6 rows
Year Kind Amount Payments
2024 Research $110,693 4
2023 Research $1,063,568 173
2022 Research $8,394,029 275
2021 Research $3,315,632 67
2020 Research $1,300,615 34
2019 Research $153,939 24

Breakdown

Who paid Research payments · program years 2019–2024
  1. Moderna TX, Inc. $6,816,035 260 payments
  2. Janssen Research & Development, LLC $6,174,106 77 payments
  3. Organon LLC $553,359 174 payments
  4. Medicines360 $327,244 22 payments
  5. Merck Sharp & Dohme Corporation $277,115 2 payments
  6. Becton, Dickinson and Company $49,981 2 payments
  7. Perrigo Company plc $42,950 1 payment
  8. Novo Nordisk AS $41,088 17 payments
  9. Rhythm Pharmaceuticals, Inc. $29,124 4 payments
  10. VYNE Pharmaceuticals Inc. $14,774 16 payments
Studies the money was for Research payments · program years 2019–2024
  1. A Phase 3, Randomized, Stratified, Observer-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Immunogenicity of mRNA-1273 SARS-CoV-2 Vaccine in Adults Aged 18 Years and Older $6,814,750 258 payments
  2. A Study of Ad26.COV2.S for the Prevention of SARSCoV2 Mediated COVID19 in Adult Participants $5,068,790 70 payments
  3. A Study of Ad26.COV2.S for the Prevention of SARS-CoV-2-Mediated COVID-19 in Adult Participants $1,105,316 7 payments
  4. Og-8175A-023 $390,011 160 payments
  5. A Phase 3 multicenter, open-label study of a Levonorgestrel 52 mg Intrauterine System for the treatment of heavy Menstrual Bleeding $327,244 22 payments
  6. A Phase 3 Randomized, Double-blind, Placebo-Controlled Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of V116 When Administered Concomitantly with Influenza Vaccine in Adults 50 Years of Age or Older $277,115 2 payments
  7. Og-8175A-023 $163,347 14 payments
  8. Veritor Antigen Assay $49,981 2 payments
  9. Bioequivalence study between Perrigo's product and Epiduo Forte Gel $42,950 1 payment
  10. Nn9536-4376 $41,088 17 payments
What the money was spent on Research payments · program years 2019–2024
  1. Patient care $566,059 176 payments

Only reported on some payments, and a payment can report more than one category, so these amounts overlap.

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2024

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record